ValiRx Plc is a biopharmaceutical company developing opportunities in the future healthcare, life sciences and biopharmaceutical industries. ValiRx is looking to acquire the rights to developmental products either in therapeutics with a particular focus, or closely related diagnostics.

Challenges:

Following the recent introduction of AIM new regulations by the London Stock Exchange, Valirx had to comply with the new AIM rules, in particular rule 26. ValiRx also recognised that in order to maintain the website compliant, it required that its staff be able to easily edit the content of new site. ValiRx also identified that it required an ongoing support which could take over, in case of emergency or important and urgent corporate communcation activities.

The Solution:

Intendance provided ValRix with a new website, which allows non-technical staff to make changes to the website with little or no training, thus enabling in-house staff to manage online investor relations.

Intendance build ValRix website using the Open Source Content Management System MySource Matrix. Being an Open Source software commercially supported, MySource Matrix proved to be the most cost effective solution on the market.